Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide enteric-coated extended-release capsules in mild to moderate Crohn's disease
CTR20140583Phase 2Active
- Sponsor
- Shanghai Sine Baoluda Pharmaceutical
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in Crohn's disease, sponsored by Shanghai Sine Baoluda Pharmaceutical. Started Jan 2015; status: active.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20140583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140583.